169 related articles for article (PubMed ID: 26649549)
1. Adrenergic blockers and the risk for common solid cancers: a case-control study.
Numbere B; Fleming KM; Walker A; Card TR
Eur J Cancer Prev; 2017 Jan; 26(1):86-93. PubMed ID: 26649549
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of the four major cancers in South Dakota.
Clarke J
S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
[TBL] [Abstract][Full Text] [Related]
3. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
4. The Use of Telmisartan and the Incidence of Cancer.
Tascilar K; Azoulay L; Dell'Aniello S; Bartels DB; Suissa S
Am J Hypertens; 2016 Dec; 29(12):1358-1365. PubMed ID: 27557862
[TBL] [Abstract][Full Text] [Related]
5. Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study.
Cohn E; Lurie I; Yang YX; Bilker WB; Haynes K; Mamtani R; Shacham-Shmueli E; Margalit O; Boursi B
J Trauma Stress; 2018 Dec; 31(6):919-926. PubMed ID: 30520529
[TBL] [Abstract][Full Text] [Related]
6. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
[TBL] [Abstract][Full Text] [Related]
7. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.
Ram P; Tiu A; Lo KB; Parikh K; Shah M
Heart Fail Rev; 2019 Nov; 24(6):989-995. PubMed ID: 31175492
[TBL] [Abstract][Full Text] [Related]
8. Cancer in Canada: Stage at diagnosis.
Bryan S; Masoud H; Weir HK; Woods R; Lockwood G; Smith L; Brierley J; Gospodarowicz M; Badets N
Health Rep; 2018 Dec; 29(12):21-25. PubMed ID: 30566206
[TBL] [Abstract][Full Text] [Related]
9. Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers.
Fleischauer AT; Poole C; Arab L
Am J Clin Nutr; 2000 Oct; 72(4):1047-52. PubMed ID: 11010950
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors of main cancer sites].
Uleckiene S; Didziapetriene J; Griciūte LL; Urbeliene J; Kasiulevicius V; Sapoka V
Medicina (Kaunas); 2008; 44(12):989-95. PubMed ID: 19142058
[TBL] [Abstract][Full Text] [Related]
11. Age- and time-dependent changes in cancer incidence among immigrants to Sweden: colorectal, lung, breast and prostate cancers.
Mousavi SM; Fallah M; Sundquist K; Hemminki K
Int J Cancer; 2012 Jul; 131(2):E122-8. PubMed ID: 22052616
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.
Mai PL; Wideroff L; Greene MH; Graubard BI
Public Health Genomics; 2010; 13(7-8):495-503. PubMed ID: 20389042
[TBL] [Abstract][Full Text] [Related]
13. Second primary colorectal cancer in the era of prevalent screening and imaging.
Bae S; Asadi M; Jones I; McLaughlin S; Bui A; Steele M; Tie J; Gibbs P
ANZ J Surg; 2013 Dec; 83(12):963-7. PubMed ID: 23528160
[TBL] [Abstract][Full Text] [Related]
14. Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women.
Heikkilä K; Nyberg ST; Theorell T; Fransson EI; Alfredsson L; Bjorner JB; Bonenfant S; Borritz M; Bouillon K; Burr H; Dragano N; Geuskens GA; Goldberg M; Hamer M; Hooftman WE; Houtman IL; Joensuu M; Knutsson A; Koskenvuo M; Koskinen A; Kouvonen A; Madsen IE; Magnusson Hanson LL; Marmot MG; Nielsen ML; Nordin M; Oksanen T; Pentti J; Salo P; Rugulies R; Steptoe A; Suominen S; Vahtera J; Virtanen M; Väänänen A; Westerholm P; Westerlund H; Zins M; Ferrie JE; Singh-Manoux A; Batty GD; Kivimäki M;
BMJ; 2013 Feb; 346():f165. PubMed ID: 23393080
[TBL] [Abstract][Full Text] [Related]
15. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum.
Wang H; Rothenbacher D; Löw M; Stegmaier C; Brenner H; Diepgen TL
Int J Cancer; 2006 Aug; 119(3):695-701. PubMed ID: 16506215
[TBL] [Abstract][Full Text] [Related]
16. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
17. Garlic and cancer: a critical review of the epidemiologic literature.
Fleischauer AT; Arab L
J Nutr; 2001 Mar; 131(3s):1032S-40S. PubMed ID: 11238811
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of cancer in the United States.
Cresanta JL
Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
[TBL] [Abstract][Full Text] [Related]
19. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
[TBL] [Abstract][Full Text] [Related]
20. Midlife Cardiorespiratory Fitness, Incident Cancer, and Survival After Cancer in Men: The Cooper Center Longitudinal Study.
Lakoski SG; Willis BL; Barlow CE; Leonard D; Gao A; Radford NB; Farrell SW; Douglas PS; Berry JD; DeFina LF; Jones LW
JAMA Oncol; 2015 May; 1(2):231-7. PubMed ID: 26181028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
